M Zaigler

472 total citations
9 papers, 380 citations indexed

About

M Zaigler is a scholar working on Pharmacology, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, M Zaigler has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 3 papers in Pharmaceutical Science and 2 papers in Molecular Biology. Recurrent topics in M Zaigler's work include Pharmacogenetics and Drug Metabolism (8 papers), Chemical Reactions and Isotopes (2 papers) and Urinary Tract Infections Management (1 paper). M Zaigler is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Chemical Reactions and Isotopes (2 papers) and Urinary Tract Infections Management (1 paper). M Zaigler collaborates with scholars based in Germany, United States and United Kingdom. M Zaigler's co-authors include Uwe Fuhr, I. Tantcheva‐Poór, Stephan Rietbrock, A. H. Staib, J. S. E. Dericks-Tan, Henning Blume, Dirk Kasel, Jędrzej Szymański, R. Böcker and Douglas Barthold and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, International Journal of Clinical Pharmacology and Therapeutics and PubMed.

In The Last Decade

M Zaigler

9 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Zaigler Germany	9	209	103	101	51	49	9	380
William Schary United States	10	220 1.1×	117 1.1×	89 0.9×	48 0.9×	113 2.3×	26	623
M.E.G. Naranjo Spain	10	305 1.5×	67 0.7×	114 1.1×	76 1.5×	55 1.1×	12	425
Monique J. Bijl Netherlands	8	218 1.0×	96 0.9×	132 1.3×	33 0.6×	84 1.7×	8	443
Michael J. Stubbins United Kingdom	7	306 1.5×	75 0.7×	123 1.2×	48 0.9×	156 3.2×	8	543
Wim J. Tamminga Netherlands	10	264 1.3×	88 0.9×	105 1.0×	85 1.7×	60 1.2×	13	492
Leif Bertilsson Sweden	8	327 1.6×	101 1.0×	134 1.3×	59 1.2×	135 2.8×	9	500
C Zekorn Germany	8	306 1.5×	48 0.5×	168 1.7×	65 1.3×	94 1.9×	10	510
Alvin N. Kotake United States	16	259 1.2×	84 0.8×	98 1.0×	67 1.3×	132 2.7×	27	663
Roza Ghotbi Sweden	6	220 1.1×	142 1.4×	77 0.8×	47 0.9×	121 2.5×	6	486
J. K. Boeijinga Netherlands	8	125 0.6×	49 0.5×	57 0.6×	61 1.2×	36 0.7×	13	348

Countries citing papers authored by M Zaigler

Since Specialization

Citations

This map shows the geographic impact of M Zaigler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Zaigler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Zaigler more than expected).

Fields of papers citing papers by M Zaigler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Zaigler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Zaigler. The network helps show where M Zaigler may publish in the future.

Co-authorship network of co-authors of M Zaigler

This figure shows the co-authorship network connecting the top 25 collaborators of M Zaigler. A scholar is included among the top collaborators of M Zaigler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Zaigler. M Zaigler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fuhr, Uwe, et al.. (2005). Rate-limiting biotransformation of triamterene is mediated by CYP1A2. International Journal of Clinical Pharmacology and Therapeutics. 43(7). 327–334. 13 indexed citations

2.

Schröder, Sven, Alexander Jetter, M Zaigler, et al.. (2004). Absorption pattern of trospium chloride along the human gastrointestinal tract assessed using local enteral administration. International Journal of Clinical Pharmacology and Therapeutics. 42(10). 543–549. 18 indexed citations

3.

Kasel, Dirk, R. Böcker, K. T. E. Beckurts, et al.. (2001). Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. International Journal of Clinical Pharmacology and Therapeutics. 39(12). 517–528. 38 indexed citations

4.

Zaigler, M, I. Tantcheva‐Poór, & Uwe Fuhr. (2000). Problems and perspectives of phenotyping for drug-metabolizing enzymes in man. International Journal of Clinical Pharmacology and Therapeutics. 38(1). 1–9. 34 indexed citations

5.

Zaigler, M, Stephan Rietbrock, Jędrzej Szymański, et al.. (2000). Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women. International Journal of Clinical Pharmacology and Therapeutics. 38(5). 235–244. 27 indexed citations

6.

Kinzig‐Schippers, M., et al.. (1999). Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2. Clinical Pharmacology & Therapeutics. 65(3). 262–274. 30 indexed citations

7.

Tantcheva‐Poór, I., M Zaigler, Stephan Rietbrock, & Uwe Fuhr. (1999). Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.. PubMed. 9(2). 131–44. 152 indexed citations

8.

Rost, Karl Ludwig, et al.. (1999). Omeprazole weakly inhibits CYP1A2 activity in man.. PubMed. 37(11). 567–74. 15 indexed citations

9.

Fuhr, Uwe, Henning Blume, S. Unger, et al.. (1998). Grapefruit juice increases oral nimodipine bioavailability.. PubMed. 36(3). 126–32. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact